390 related articles for article (PubMed ID: 12481798)
1. Current issues in clinical research and the development of new pharmaceuticals.
Goldhammer A
Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
4. Bioethical malpractice: risk and responsibilities in human research.
Noah BA
J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
[No Abstract] [Full Text] [Related]
5. Research involving children: regulations, review boards and reform.
Gandhi R
J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
[No Abstract] [Full Text] [Related]
6. Protecting research subjects--what must be done.
Shalala D
N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
[No Abstract] [Full Text] [Related]
7. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
8. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials face heightened scrutiny as science and commerce appear to merge.
Lorman AJ
J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
[TBL] [Abstract][Full Text] [Related]
10. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations.
Kelleher F
Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695
[TBL] [Abstract][Full Text] [Related]
11. Recurrent issues in the review of medical research on human subjects.
Moore DL
Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
[No Abstract] [Full Text] [Related]
12. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
[TBL] [Abstract][Full Text] [Related]
13. Extend the reach of institutional review boards first, then strengthen their depth.
Spike J
Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
[No Abstract] [Full Text] [Related]
14. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
James JS
AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
[TBL] [Abstract][Full Text] [Related]
15. Improving protection for research subjects.
Steinbrook R
N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
[No Abstract] [Full Text] [Related]
16. When do the federal regulations allow placebo-controlled trials in children?
Miller FG; Wendler D; Wilfond B
J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
[No Abstract] [Full Text] [Related]
17. Regulating clinical research: informed consent, privacy, and IRBs.
Hoffman S
Cap Univ Law Rev; 2003; 31(1):71-91. PubMed ID: 15295833
[No Abstract] [Full Text] [Related]
18. The use of placebos in clinical trials: responsible research or unethical practice?
Hoffman S
Conn Law Rev; 2001; 33(2):449-501. PubMed ID: 15732201
[No Abstract] [Full Text] [Related]
19. When informed consent is not required in studies.
Maloney DM
Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
[No Abstract] [Full Text] [Related]
20. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
Breslow LH
Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
